<p>(A) H9c2 rat immortalized cardiomyoblasts were cultured with reduced FBS (1%) for up to 72 hours in 96-well culture plates under indicated conditions. Viability levels were estimated as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0104888#s2" target="_blank">Materials and Methods</a>. (B) LDH leakages in H9c2 cells after Dox/Met treatment. Cells were treated with indicated conditions for 24 hours in serum free medium. LDH levels in culture supernatants were evaluated using LDH assay kit. (C) H9c2 cells were cultured on poly-L-lysine coated chamber slides for 24 hours under the conditions as indicated in reduced FBS medium. The slides were immunostained with anti-Ki-67 antibody (BD Biosciences) and AL...
<div><p>Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiot...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
H9c2 cells were treated with DOX (0 and 10 μg/mL) for 0–5 h and uptake of Galmydar (20μM, 60 min) wa...
<p>(A) Rat neonatal primary cardiomyocytes (CM) and H9c2 cardiomyoblasts were cultured with reduced ...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, and then cell lysates ...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, with indicated conditi...
H9c2 cells were treated with different doses of DOX (A) or CA (B), and then cell viability was measu...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, with indicated conditi...
<p>Figure A to H showed the morphology of rat cardiomyocyte monolayer (×400). Control cells were not...
In accordance with requirements of the ICH S7B safety pharmacology guidelines, numerous next-generat...
<p>H9c2 cardiomyocytes were treated with vehicle or Dox for 0 h to 36 h and ROS fluorescence was dete...
<p>An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to detec...
<p>H9c2 cardiomyocytes were treated for 6, 12, 24 and 36 h with different concentrations of Dox, and...
Controversial results have been reported regarding whether metallothionein (MT) functions in doxorub...
Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiotoxicity ...
<div><p>Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiot...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
H9c2 cells were treated with DOX (0 and 10 μg/mL) for 0–5 h and uptake of Galmydar (20μM, 60 min) wa...
<p>(A) Rat neonatal primary cardiomyocytes (CM) and H9c2 cardiomyoblasts were cultured with reduced ...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, and then cell lysates ...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, with indicated conditi...
H9c2 cells were treated with different doses of DOX (A) or CA (B), and then cell viability was measu...
<p>(A) H9c2 cardiomyoblasts were cultured with reduced FBS (1%) for 72 hours, with indicated conditi...
<p>Figure A to H showed the morphology of rat cardiomyocyte monolayer (×400). Control cells were not...
In accordance with requirements of the ICH S7B safety pharmacology guidelines, numerous next-generat...
<p>H9c2 cardiomyocytes were treated with vehicle or Dox for 0 h to 36 h and ROS fluorescence was dete...
<p>An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to detec...
<p>H9c2 cardiomyocytes were treated for 6, 12, 24 and 36 h with different concentrations of Dox, and...
Controversial results have been reported regarding whether metallothionein (MT) functions in doxorub...
Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiotoxicity ...
<div><p>Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiot...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
H9c2 cells were treated with DOX (0 and 10 μg/mL) for 0–5 h and uptake of Galmydar (20μM, 60 min) wa...